The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients

被引：0
|
作者：
Weng, Fangbin [1 ]
Li, Xiaofei [1 ]
机构：
[1] YiWu Cent Hosp, Dept Infect Dis, Yiwu 322000, Zhejiang, Peoples R China
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2021年 / 120卷 / 01期
关键词：
ADVANCED AGE; HEMOGLOBIN;
D O I：
10.1016/j.jfma.2020.08.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [41] Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
    Tsung-Hsing Hung
    Chen-Chi Tsai
    Chung-Chi Lin
    Hsing-Feng Lee
    Chi-Jen Chu
    Han-Chieh Lin
    Hepatology International, 2013, 7 : 676 - 682
  • [42] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Burroughs, Andrew
    Samonakis, Dirnitrios
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 78 - 79
  • [43] Selective and sequential transarterial chemoembolization: Survival in patients with hepatocellular carcinoma
    Antoch, Gerald
    Roelle, Grit
    Ladd, Susanne C.
    Kuehl, Hilmar
    Heusner, Till A.
    Sotiropoulos, Georgios C.
    Hilgard, Philip
    Forsting, Michael
    Verhagen, Ruediger
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (09) : 2290 - 2297
  • [44] Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma
    Holowko, Waclaw
    Wroblewski, Tadeusz
    Wojtaszek, Mikolaj
    Grat, Michal
    Kobryn, Konrad
    Ziarkiewicz-Wrolewska, Bogna
    Krawczyk, Marek
    ANNALS OF TRANSPLANTATION, 2015, 20
  • [45] Changes of tryptase in patients with hepatocellular carcinoma after transarterial chemoembolization
    Min, Xu-Li
    Yang, Lin
    Zhang, Xiao-Ming
    Zhou, Yi
    Miao, Nan-Dong
    Ren, Yong-Jun
    Xu, Hao
    Liu, Kang
    Peng, Juan
    Yang, Ke
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (06) : 1061 - 1067
  • [46] Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma
    Wang, Peng
    Sheng, Lili
    Wang, Guoxiang
    Wang, Heping
    Huang, Xinyu
    Yan, Xiaoxing
    Yang, Xiaohua
    Pei, Renguang
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 203 - 206
  • [47] Improving Outcomes for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma
    McCurdy, Heather M.
    GASTROENTEROLOGY NURSING, 2013, 36 (02) : 114 - 120
  • [48] Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
    Hung, Tsung-Hsing
    Tsai, Chen-Chi
    Lin, Chung-Chi
    Lee, Hsing-Feng
    Chu, Chi-Jen
    Lin, Han-Chieh
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 676 - 682
  • [49] Transarterial Chemoembolization with Miriplatin plus Epirubicin in Patients with Hepatocellular Carcinoma
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Saito, Tomoko
    Motoyama, Tenyu
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    ANTICANCER RESEARCH, 2015, 35 (01) : 549 - 554
  • [50] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Andrew Burroughs
    Dimitrios Samonakis
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 78 - 79
12345